|
Volumn 124, Issue 1-3, 2001, Pages 70-72
|
Engineering, characterization and in vitro efficacy of the major peanut allergens for use in immunotherapy
|
Author keywords
Allergens; Hypoallergenic; Immunotherapy; Peanut allergy
|
Indexed keywords
ALLERGEN;
AMINO ACID;
COMPLEMENTARY DNA;
EPITOPE;
IMMUNOGLOBULIN E;
RECOMBINANT PROTEIN;
ANAPHYLAXIS;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
CONFERENCE PAPER;
CONTROLLED STUDY;
DESENSITIZATION;
DRUG EFFICACY;
FOOD ALLERGY;
GENETIC ENGINEERING;
HUMAN;
HUMAN CELL;
IMMUNOBLOTTING;
IMMUNOTHERAPY;
IN VITRO STUDY;
LYMPHOCYTE PROLIFERATION;
MONONUCLEAR CELL;
MOUSE;
NONHUMAN;
PEANUT;
PRIORITY JOURNAL;
SITE DIRECTED MUTAGENESIS;
T LYMPHOCYTE;
ALLERGENS;
ANAPHYLAXIS;
ANIMALS;
ARACHIS HYPOGAEA;
DESENSITIZATION, IMMUNOLOGIC;
FOOD HYPERSENSITIVITY;
GENES, PLANT;
GENETIC ENGINEERING;
GLYCOPROTEINS;
HUMANS;
IMMUNOGLOBULIN E;
LYMPHOCYTE ACTIVATION;
MICE;
MUTAGENESIS, SITE-DIRECTED;
PLANT PROTEINS;
|
EID: 0035044672
PISSN: 10182438
EISSN: None
Source Type: Journal
DOI: 10.1159/000053672 Document Type: Conference Paper |
Times cited : (124)
|
References (12)
|